Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Mirikizumab en risankizumab vergeleken met ustekinumab bij ziekte van Crohn
jul 2024 | IBD